ArticleNPJ science of food2026
Gallic acid antagonizes deoxynivalenol toxicity by inhibiting DON-induced ferroptosis.
Article in NPJ science of food, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Deoxynivalenol (DON) is a prevalent foodborne mycotoxin severely compromising livestock and poultry health and food safety. This study evaluated gallic acid (GA) -a top-performing candidate among screened polyphenols-in counteracting DON toxicity. In chicken embryo fibroblasts, 0.5 μM DON reduced viability to ~55% and induced oxidative stress, while co-treatment with 160 μM GA restored viability to ~79%. In chicks, DON caused hepatic injury and intestinal villus shortening, effects that GA effectively mitigated. Transcriptomic and biochemical assays revealed that DON triggers ferroptosis by disrupting iron homeostasis and lipid peroxidation elevation, whereas GA activated the Nrf2 pathway and upregulated key cytoprotective genes (GPX4, FTH1, SLC7A11, HO-1) to inhibit ferroptosis. These results demonstrate that GA antagonizes DON toxicity primarily through Nrf2-mediated ferroptosis suppression. In summary, this investigation provided not only a mechanistic basis for GA's standalone application but also a rationale for targeted combinatorial therapy from multi-mechanistic perspectives to alleviate DON-induced damage and safeguard animal health and food safety.
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.